Philip J. Lupo

Lupo

Philip J. Lupo, Ph.D.

Professor

(713) 798-2960

Positions

Professor
Pediatrics
Hematology-Oncology
Baylor College of Medicine
Houston, TX, US
Co-Leader, Cancer Prevention & Population Sciences Program
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Addresses

Baylor Clinic (Office)
6620 Main Street
BCLN-11D.26
Houston, TX, 77030
United States

Education

Post-Doctoral Fellowship at University of Texas Health Science Center
08/2010 - Houston, Texas, United States
Genetic Epidemiology
PhD from University of Texas Health Science Center
08/2009 - Houston, Texas, United States
Epidemiology
MPH from University of Texas Health Science Center
08/2004 - Houston, Texas, United States
Disease Control
BS from Houston Baptist University
05/1996 - Houston, Texas, United States
Biology, Political Science

Honors & Awards

Delta Omega, Honorary Society in Public Health
(05/2010)
Pediatric Loan Repayment Program
National Institutes of Health (10/2011 - 09/2015)
Research Mentoring Award
University of Texas School of Public Health (08/2012)
Kurt Groten Family Research Scholars Award
(07/2012 - 06/2015)
Annual Investigator Meeting Travel Award
Childhood Cancer Survivor Study (06/2013)
Invited participant, Integrative Molecular Epidemiology Workshop
American Association for Cancer Research (07/2013)
“Top Abstracts” recipient
American Society of Preventive Oncology (03/2014)
Best Poster
National Birth Defects Prevention Network 18th Annual Meeting (10/2015)
Top Scoring Abstracts Award
49th Congress of the International Society of Paediatric Oncology (10/2017)
Best Poster
National Birth Defects Prevention Network 21st Annual Meeting (03/2018)
F. Clarke Fraser New Investigator Award
Teratology Society (06/2018)

Professional Interests

  • Cancer epidemiology
  • Genetic epidemiology
  • Childhood cancer
  • Overlap between birth defects and childhood cancer
  • Epidemiology of birth defects

Professional Statement

The ultimate goal of my research is to discover factors that can be used in childhood cancer prevention efforts and targeted interventions to limit the adverse consequences of childhood cancer treatment.

Selected Publications

Memberships

American Association for Cancer Research
Member (01/2008)
Childhood Cancer and Leukemia International Consortium
Member (01/2011)
Children’s Oncology Group
Chair, Epidemiology Committee (07/2012)
International Society of Paediatric Oncology
Member (01/2015)
Advisory Committee to the Texas Cancer Registry
Member (07/2016)
Society for Birth Defects Research and Prevention
Member (09/2017)
National Birth Defects Prevention Network
Member (01/2008)

Funding

Epigenomic Profiling of Metabolic Outcomes in Childhood Leukemia Survivors
#U24CASS727 (Parent grant ID)
$20,000.00   (12/01/2013 - 11/30/2014)
Grant funding from Childhood Cancer Survivor Study (CCSS)/NCI
Exploring the Intersection Between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes
#Epidemiology Grant
$200,000.00   (07/01/2014 - 06/30/2016)
Grant funding from Alex's Lemonade Stand Foundation
The Intersection between Childhood Cancer and Congenital Anomalies: Identifying Novel Cancer Predisposition Syndromes
#RP140258
$874,964.00   (08/31/2014 - 08/30/2017)
Grant funding from Cancer Prevention & Research Institute of Texas (CPRIT)
Genetic Epidemiology and Molecular Basis of Cancer Predisposition in Pediatric Rhabdomyosarcoma
#RP170071
$1,488,105.00   (12/01/2016 - 11/30/2019)
Grant funding from CPRIT
Molecular Epidemiology And Somatic Alterations Driving Acute Lymphoblastic Leukemia In Down Syndrome
#RP170074
$1,200,000.00   (12/01/2016 - 11/30/2020)
Grant funding from CPRIT
Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium
$2,000,000.00   (07/01/2017 - 06/30/2021)
Grant funding from St. Baldrick's Foundation
The Early-Life Exposome and Risk of Pediatric Acute Lymphoblastic Leukemia
#RP180755
$199,140.00   (08/31/2018 - 08/30/2020)
Grant funding from CPRIT
A Multidisciplinary Approach for Identifying and Characterizing Novel Congenital Malformation Syndromes
#R01HD093660
$1,662,692.00   (08/25/2018 - 06/30/2023)
Grant funding from NIH/NICHD
Genomic Analysis of Congenital Heart Defects and Acute Lymphoblastic Leukemia in Children with Down Syndrome
#X01HL145686
(10/01/2018 - 09/30/2019)
Grant funding from NIH
Genomic Analysis of Pediatric Rhabdomyosarcoma
#X01HD100852
(10/01/2019 - 09/30/2020)
Grant funding from NIH
Molecular Epidemiology of Acute Lymphoblastic Leukemia in Children with Down Syndrome
#R01CA249867
$2,130,791.00   (08/03/2020 - 07/31/2023)
Grant funding from NIH/NCI
Identifying Novel Cancer Predisposition Syndromes: An Integrative Epidemiologic and Genomic Approach
#CA190214
$1,000,000.00   (08/15/2020 - 08/14/2023)
Grant funding from DOD

Log In to edit your profile